Similar to CML CD34+ cells, gene profiling indicate components of the BMP pathway were differentially expressed in CML-iPSCs compared to normal iPSCs, with BMP2 strongly downregulated and SMURF1 strongly upregulated (Fig. 6c). The gene discussed is BMP2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.